Form 4: Encompass Health Director Gains RSUs via Dividend

Encompass Health Corp. Director Joan E. Herman received 87 restricted stock units on January 15, 2026, as part of a routine dividend payment.

Summary

• Joan E. Herman, a Director of Encompass Health Corp. (EHC), acquired 87 restricted stock units (RSUs) on January 15, 2026.
• The acquisition was a non-cash transaction, with a reported price of $0, as the RSUs were credited in connection with a common stock dividend payment.
• The number of RSUs credited is calculated based on the number of RSUs in the director's account, the per share dividend, and the closing price on the dividend payment date.
• Encompass Health paid a dividend of $0.19 per share on its common stock on January 15, 2026.
• The closing price of Encompass Health common stock on the dividend payment date was $102.80.
• Following this transaction, Joan E. Herman beneficially owns 47,839 restricted stock units directly.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to an increase in director ownership, albeit through a routine RSU award, which generally aligns director and shareholder interests. There are no negative implications from this filing.

Positives

• The transaction increases the beneficial ownership of a director in Encompass Health Corp., aligning management interests with shareholders.
• The RSU award is a standard component of non-employee director compensation, reflecting a routine corporate governance practice.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

The crediting of restricted stock units to non-employee directors in connection with common stock dividend payments is a standard practice in many publicly traded companies, serving as a form of equity compensation and aligning director interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The increase in director's beneficial ownership through RSUs can be viewed positively as it further aligns the director's financial interests with the company's long-term performance and shareholder returns.

Key Dates

Recommendation

This Form 4 filing details a routine, non-cash acquisition of restricted stock units by a director as part of a compensation plan tied to a dividend. While it indicates continued alignment of director interests with shareholders, it does not present new information significant enough to alter an investment thesis or warrant a 'buy' or 'sell' recommendation. The transaction is expected and does not reflect a discretionary purchase or sale based on new material information.

Keywords

Encompass Health, EHC, Form 4, Insider Transaction, Restricted Stock Units, RSU, Dividend, Director Compensation, Corporate Governance, Equity Award